The leading clinical outsourcing roadshow for the biotech, pharma, & medical device industries. Benefit from an unrivalled line up of speakers, including 11 small/medium and biotech, 8 c-level presenters, leading academics, investors and clinical experts.
International Pharmaceutical Expo (INTERPHEX) is the single source for complete biopharmaceutical and pharmaceutical manufacturing solutions to confidently process all dosage forms for life-enhancing drugs.
Quality management and GCP is increasingly scrutinised by regulators, Informa’s GCP and Quality in Clinical Trials event has been designed to tackle the current issues that are affecting quality and compliance.
Partnerships in Clinical Trials Asia is an annual event that brings together 150+ global and regional pharma, biotech, CROs, regulators and clinical trial solution providers to network, learn, strategize and advance next practices in clinical trials in the region and forge more effective partnerships.
Clinical quality, compliance, operations and management professionals gather to discuss strategies for ensuring trial integrity by effectively assessing, optimizing and managing the quality of clinical vendors and sites.
At the Procurement and Outsourcing for Life Sciences Congress you will receive crucial information on how to identify new business needs, address major challenges in sourcing and procurement, reduce costs, maximize working capital, and more.
This October, DIA will bring together key thought leaders and experts from various fields in life sciences to explore the impact of the “global village” on local government, industry and health care providers.
Creators, innovators, storytellers and rising stars will come together at the 13th Annual Partnerships in Clinical Trials Congress, 5-6 November 2014 at the CCIB, Barcelona, Spain to provoke change and demand solutions to advancing clinical trial collaborations.
During this three-day meeting, thought leaders from around the world will provide their insight and engage in dialogue on current opportunities and challenges in managing product risk in the context of benefit.